Significance of the Gut-Brain Axis in the Development of Overweight and Obesity
DOI:
https://doi.org/10.12775/JEHS.2024.70.49434Keywords
gastrointestinal microbiome, brain-gut axis, overweight, obesityAbstract
Introduction: The global obesity crisis results from inactive lifestyles and poor diets, increasing the risk of metabolic disorders. Emerging research links obesity with gut microbiome changes influenced by factors like age, genetics, and diet. Gut-brain communication via neural, endocrine, and inflammatory pathways, influenced by microbial compounds, affects nervous system function.
Materials and Methods of Research: A thorough literature review was performed using PubMed and Google Scholar, employing keywords related to the gut-brain axis and obesity.
Results: Obesity shifts gut microbiota composition due to factors like childbirth method, diet, antibiotics, and environment. This imbalance impacts metabolism, appetite, and insulin sensitivity. Gut microbes influence the brain, regulating energy balance and inflammation. Dysregulated tryptophan metabolism leads to insulin resistance. Gut-brain communication via the vagal nerve affects nutrient metabolism. Hormones like insulin and leptin, along with microbial metabolites, affect lipid metabolism and appetite. Gut microbiota abundance correlates with leptin signaling, and changes in ghrelin levels relate to microbiota composition. Microbial presence affects food cravings. Inflammation in obesity is linked to gut microbiota changes, mediated by bile acids and microbial metabolites. Interventions like probiotics and fecal microbiota transplantation offer potential for managing obesity. Emerging therapies like peptide D3 hold promise but require further study.
Conclusion: The microbiome-gut-brain axis is vital in obesity, affecting metabolism, inflammation, and appetite. Utilizing interventions such as dietary adjustments and probiotics targeting gut-brain signaling shows promise in managing obesity. Personalized approaches are crucial due to microbiome complexity. Further research is needed to develop effective therapies for the obesity epidemic.
References
Zhang X, Ha S, Lau HC, Yu J. Excess body weight: Novel insights into its roles in obesity comorbidities. s.l.: Semin Cancer Biol. 2023 Jul; 92:16-27. doi: 10.1016/j.semcancer.2023.03.008. Epub2023 Mar 24. PMID: 36965839.
Kessler, Christine. Pathophysiology of Obesity. s.l. : Nursing Clinics of North America, Volume 56, Issue 4, 2021, Pages 465-478, ISSN 0029-6465, ISBN 9780323835220, https://doi.org/10.1016/j.cnur.2021.08.001.
M., Blüher. Obesity: global epidemiology and pathogenesis. s.l. : Nat Rev Endocrinol. 2019 May;15(5):288-298. doi: 10.1038/s41574-019-0176-8. PMID: 30814686.
Gong J, Shen Y, Zhang H, Cao M, Guo M, He J, Zhang B, Xiao C. Gut Microbiota Characteristics of People with Obesity by Meta-Analysis of Existing Datasets. s.l. : Nutrients. 2022 Jul 21;14(14):2993. doi: 10.3390/nu14142993. PMID: 35889949; PMCID: PMC9325184.
Cryan, J. F., O’Riordan, K. J., Cowan, C. S. M., Sandhu, K. V., Bastiaanssen, T. F. S., Boehme, M., … Dinan, T. G. (2019). The Microbiota-Gut-Brain Axis. Physiological Reviews, 99(4), 1877–2013. doi:10.1152/physrev.00018.2018.
Adak, A., Khan, M.R. An insight into gut microbiota and its functionalities. s.l. : Cell. Mol. Life Sci. 76, 473–493 (2019). https://doi.org/10.1007/s00018-018-2943-4.
Osadchiy V, Martin CR, Mayer EA. The Gut-Brain Axis and the Microbiome: Mechanisms and Clinical Implications. s.l. : Clin Gastroenterol Hepatol. 2019 Jan;17(2):322-332. doi: 10.1016/j.cgh.2018.10.002. Epub 2018 Oct 4. PMID: 30292888; PMCID: PMC6999848.
Margolis KG, Cryan JF, Mayer EA. The Microbiota-Gut-Brain Axis: From Motility to Mood. s.l. : Gastroenterology. 2021 Apr;160(5):1486-1501. doi: 10.1053/j.gastro.2020.10.066. Epub 2021 Jan 22. PMID: 33493503; PMCID: PMC8634751.
Gagliardi A, Totino V, Cacciotti F, Iebba V, Neroni B, Bonfiglio G, Trancassini M, Passariello C, Pantanella F, Schippa S. Rebuilding the Gut Microbiota Ecosystem. s.l. : Int J Environ Res Public Health. 2018 Aug 7;15(8):1679. doi: 10.3390/ijerph15081679. PMID: 30087270; PMCID: PMC6121872.
Ching-Hung Tseng, Chun-Ying Wu. The gut microbiome in obesity. s.l. : Journal of the Formosan Medical Association, 2019-03-01, Volume 118, Pages S3-S9, Copyright © 2018.
Bianchi, F., Duque, A.L.R.F., Saad, S.M.I. et al. Gut microbiome approaches to treat obesity in humans. s.l. : Appl Microbiol Biotechnol 103, 1081–1094 (2019). https://doi.org/10.1007/s00253-018-9570-8.
Thursby E, Juge N. Introduction to the human gut microbiota. s.l. : Biochem J. 2017 May 16;474(11):1823-1836. doi: 10.1042/BCJ20160510. PMID: 28512250; PMCID: PMC5433529
Bailén M, Bressa C, Martínez-López S, González-Soltero R, Montalvo Lominchar MG, San Juan C, Larrosa M. Microbiota Features Associated With a High-Fat/Low-Fiber Diet in Healthy Adults. s.l. : Front Nutr. 2020 Dec 18;7:583608. doi: 10.3389/fnut.2020.583608. PMID: 33392236; PMCID: PMC7775391.
Singh RK, Chang HW, Yan D, Lee KM, Ucmak D, Wong K, Abrouk M, Farahnik B, Nakamura M, Zhu TH, Bhutani T, Liao W. Influence of diet on the gut microbiome and implications for human health. s.l. : J Transl Med. 2017 Apr 8;15(1):73. doi: 10.1186/s12967-017-1175-y. PMID: 28388917; PMCID: PMC5385025.
D., Martini. Health Benefits of Mediterranean Diet. s.l. : Nutrients. 2019 Aug 5;11(8):1802. doi: 10.3390/nu11081802. PMID: 31387226; PMCID: PMC6723598.
Klancic T, Reimer RA. Gut microbiota and obesity: Impact of antibiotics and prebiotics and potential for musculoskeletal health. s.l. : J Sport Health Sci. 2020 Mar;9(2):110-118. doi: 10.1016/j.jshs.2019.04.004. Epub 2019 May 3. PMID: 32099719; PMCID: PMC7031774.
Lee CJ, Sears CL, Maruthur N. Gut microbiome and its role in obesity and insulin resistance. s.l. : Ann N Y Acad Sci. 2020 Feb;1461(1):37-52. doi: 10.1111/nyas.14107. Epub 2019 May 14. PMID: 31087391.
Han H, Yi B, Zhong R, Wang M, Zhang S, Ma J, Yin Y, Yin J, Chen L, Zhang H. From gut microbiota to host appetite: gut microbiota-derived metabolites as key regulators. s.l. : Microbiome. 2021 Jul 20;9(1):162. doi: 10.1186/s40168-021-01093-y. PMID: 34284827; PMCID: PMC8293578.
Ramírez-Pérez O, Cruz-Ramón V, Chinchilla-López P, Méndez-Sánchez N. The Role of the Gut Microbiota in Bile Acid Metabolism. s.l. : Ann Hepatol. 2017 Nov; 16(Suppl. 1: s3-105.):s15-s20. doi: 10.5604/01.3001.0010.5494. PMID: 29080339.
Cheng Z, Zhang L, Yang L, Chu H. The critical role of gut microbiota in obesity. s.l. : Front Endocrinol (Lausanne). 2022 Oct20; 13:1025706. doi: 10.3389/fendo.2022.1025706. PMID: 36339448; PMCID: PMC9630587.
Heiss CN, Olofsson LE. Gut Microbiota-Dependent Modulation of Energy Metabolism. s.l. : J Innate Immun. 2018;10(3):163-171. doi: 10.1159/000481519. Epub 2017 Nov 8. PMID: 29131106; PMCID: PMC6757175.
Amabebe E, Robert FO, Agbalalah T, Orubu ESF. Microbialdysbiosis-induced obesity: role of gut microbiota in homoeostasis of energy metabolism. s.l. : Br J Nutr. 2020 May 28;123(10):1127-1137. doi: 10.1017/S0007114520000380. Epub 2020 Feb 3. PMID: 32008579.
Agus A, Planchais J, Sokol H. Gut Microbiota Regulation of Tryptophan Metabolism in Health and Disease. s.l. : Cell Host Microbe. 2018 Jun 13;23(6):716-724. doi: 10.1016/j.chom.2018.05.003. PMID: 29902437.
Agus A, Clément K, Sokol H. Gut microbiota-derived metabolites as central regulators in metabolic disorders. s.l. : Gut. 2021 Jun;70(6):1174-1182. doi: 10.1136/gutjnl-2020-323071. Epub 2020 Dec 3. PMID: 33272977; PMCID: PMC8108286.
Wang SZ, Yu YJ, Adeli K. Role of Gut Microbiota in Neuroendocrine Regulation of Carbohydrate and Lipid Metabolism via the Microbiota-Gut-Brain-Liver Axis. s.l. : Microorganisms. 2020 Apr 7;8(4):527. doi: 10.3390/microorganisms8040527. PMID: 32272588; PMCID: PMC7232453.
Espinoza García AS, Martínez Moreno AG, Reyes Castillo Z. The role of ghrelin and leptin in feeding behavior: Genetic and molecular evidence. s.l. : Endocrinol Diabetes Nutr (Engl Ed). 2021 Nov;68(9):654-663. doi: 10.1016/j.endien.2020.10.009. Epub 2021 Dec 3. PMID: 34906346.
Kolb H, Kempf K, Röhling M, Martin S. Insulin: too much of a good thing is bad. s.l. : BMC Med. 2020 Aug 21;18(1):224. doi: 10.1186/s12916-020-01688-6. PMID: 32819363; PMCID: PMC7441661.
Hernández MAG, Canfora EE, Jocken JWE, Blaak EE. The Short-Chain Fatty Acid Acetate in Body Weight Control and Insulin Sensitivity. s.l. : Nutrients. 2019 Aug 18;11(8):1943. doi: 10.3390/nu11081943. PMID: 31426593; PMCID: PMC6723943.
Xu J, Bartolome CL, Low CS, Yi X, Chien CH, Wang P, Kong D. Genetic identification of leptin neural circuits in energy and glucose homeostases. s.l. : Nature. 2018 Apr;556(7702):505-509. doi: 10.1038/s41586-018-0049-7. Epub 2018 Apr 18. PMID: 29670283; PMCID: PMC5920723.
Poher AL, Tschöp MH, Müller TD. Ghrelin regulation of glucose metabolism. s.l. : Peptides. 2018 Feb;100:236-242. doi: 10.1016/j.peptides.2017.12.015. PMID: 29412824; PMCID: PMC5805851.
J., Davis. Hunger, ghrelin and the gut. Vols. Brain Res. 2018 Aug 15;1693(Pt B):154-158. doi: 10.1016/j.brainres.2018.01.024. Epub 2018 Jan 31. PMID: 29366626.
Torres-Fuentes C, Golubeva AV, Zhdanov AV, Wallace S, Arboleya S, Papkovsky DB, Aidy SE, Ross P, Roy BL, Stanton C, Dinan TG, Cryan JF, Schellekens H. Short-chain fatty acids and microbiota metabolites attenuate ghrelin receptor signaling. s.l. : FASEB J. 2019 Dec;33(12):13546-13559. doi: 10.1096/fj.201901433R. Epub 2019 Oct 9. PMID: 31545915.
Barakat GM, Ramadan W, Assi G, Khoury NBE. Satiety: a gut-brain-relationship. s.l. : J PhysiolSci. 2024 Feb 17;74(1):11. doi: 10.1186/s12576-024-00904-9. PMID: 38368346; PMCID: PMC10874559.
Tilg H, Zmora N, Adolph TE, Elinav E. The intestinal microbiota fuelling metabolic inflammation. s.l. : Nat Rev Immunol. 2020 Jan;20(1):40-54. doi: 10.1038/s41577-019-0198-4. Epub 2019 Aug 6. PMID: 31388093.
Chávez-Talavera O, Tailleux A, Lefebvre P, Staels B. Bile Acid Control of Metabolism and Inflammation in Obesity, Type 2 Diabetes, Dyslipidemia, and Nonalcoholic Fatty Liver Disease. s.l. : Gastroenterology. 2017 May;152(7):1679-1694.e3. doi: 10.1053/j.gastro.2017.01.055. Epub 2017 Feb 15. PMID: 28214524.
He J, Zhang P, Shen L, Niu L, Tan Y, Chen L, Zhao Y, Bai L, Hao X, Li X, Zhang S, Zhu L. Short-Chain Fatty Acids and Their Association with Signalling Pathways in Inflammation, Glucose and Lipid Metabolism. s.l. : Int J Mol Sci. 2020 Sep 2;21(17):6356. doi: 10.3390/ijms21176356. PMID: 32887215; PMCID: PMC7503625.
Cerdó T, García-Santos JA, G Bermúdez M, Campoy C. The Role of Probiotics and Prebiotics in the Prevention and Treatment of Obesity. s.l. : Nutrients. 2019 Mar 15;11(3):635. doi: 10.3390/nu11030635. PMID: 30875987; PMCID: PMC6470608.
Alissa C. Nicolucci, Megan P. Hume, Inés Martínez, Shyamchand Mayengbam, Jens Walter, Raylene A. Reimer. Prebiotics Reduce Body Fat and Alter Intestinal Microbiota in Children Who Are Overweight or With Obesity. s.l. : Gastroenterology, 2017-09-01, Volume 153, Issue 3, Pages 711-722, Copyright © 2017 AGA Institute.
Vallianou, N., Stratigou, T., Christodoulatos, G.S. et al. Probiotics, Prebiotics, Synbiotics, Postbiotics, and Obesity: Current Evidence, Controversies, and Perspectives. s.l. : Curr Obes Rep 9, 179–192 (2020). https://doi.org/10.1007/s13679-020-00379-w.
Aron-Wisnewsky J, Clément K, Nieuwdorp M. Fecal Microbiota Transplantation: a Future Therapeutic Option for Obesity/Diabetes? s.l. : Curr Diab Rep. 2019 Jun 27;19(8):51. doi: 10.1007/s11892-019-1180-z. PMID: 31250122.
Li Z, Zhang B, Wang N, Zuo Z, Wei H, Zhao F. A novel peptide protects against diet-induced obesity by suppressing appetite and modulating the gut microbiota. s.l. : Gut. 2023 Apr;72(4):686-698. doi: 10.1136/gutjnl-2022-328035. Epub 2022 Jul 8. PMID: 35803703; PMCID: PMC10086289.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Martyna Kuśmierska, Jakub Kuśmierski, Izabela Janik, Anna Martyka, Przemysław Ujma

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
The periodical offers access to content in the Open Access system under the Creative Commons Attribution-NonCommercial-ShareAlike 4.0
Stats
Number of views and downloads: 309
Number of citations: 0